Learn more: PMC Disclaimer | PMC Copyright Notice
Profile of urinary arsenic metabolites during pregnancy.
Abstract
Chronic exposure to inorganic arsenic (In-As) from drinking water is associated with different health effects, including skin, lung, bladder, and kidney cancer as well as vascular and possibly reproductive effects. In-As is metabolized through the process of methylation, resulting in the production and excretion of methylated species, mainly monomethylarsenate (MMA) and dimethylarsenate (DMA). Because a large percentage of the dose is excreted in urine, the distribution of urinary In-As, MMA, and DMA is considered a useful indicator of methylation patterns in human populations. Several factors affect these patterns, including sex and exposure level. In this study, we investigated the profile of urinary In-As, MMA, and DMA of pregnant women. Periodic urine samples were collected from early to late pregnancy among 29 pregnant women living in Antofagasta, Chile, who drank tap water containing 40 micro g/L In-As. The total urinary arsenic across four sampling periods increased with increasing weeks of gestation, from an initial mean value of 36.1 to a final value of 54.3 micro g/L. This increase was mainly due to an increase in DMA, resulting in lower percentages of In-As and MMA and a higher percentage of DMA. Our findings indicate that among women exposed to moderate arsenic from drinking water during pregnancy, changes occur in the pattern of urinary arsenic excretion and metabolite distribution. The toxicologic significance of this is not clear, given recent evidence suggesting that intermediate methylated species may be highly toxic. Nevertheless, this study suggests that arsenic metabolism changes throughout the course of pregnancy, which in turn may have toxicologic effects on the developing fetus. Key words: arsenic, arsenic metabolism, arsenic methylation, Chile, pregnancy, urinary arsenic.
Full Text
The Full Text of this article is available as a PDF (132K).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aposhian HV, Arroyo A, Cebrian ME, del Razo LM, Hurlbut KM, Dart RC, Gonzalez-Ramirez D, Kreppel H, Speisky H, Smith A, et al. DMPS-arsenic challenge test. I: Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate. J Pharmacol Exp Ther. 1997 Jul;282(1):192–200. [PubMed] [Google Scholar]
- Concha G, Vogler G, Lezcano D, Nermell B, Vahter M. Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci. 1998 Aug;44(2):185–190. [PubMed] [Google Scholar]
- Cuzick J. A Wilcoxon-type test for trend. Stat Med. 1985 Jan-Mar;4(1):87–90. [PubMed] [Google Scholar]
- Del Razo LM, Styblo M, Cullen WR, Thomas DJ. Determination of trivalent methylated arsenicals in biological matrices. Toxicol Appl Pharmacol. 2001 Aug 1;174(3):282–293. [PubMed] [Google Scholar]
- Hopenhayn-Rich C, Biggs ML, Kalman DA, Moore LE, Smith AH. Arsenic methylation patterns before and after changing from high to lower concentrations of arsenic in drinking water. Environ Health Perspect. 1996 Nov;104(11):1200–1207. [PMC free article] [PubMed] [Google Scholar]
- Hopenhayn-Rich C, Biggs ML, Smith AH, Kalman DA, Moore LE. Methylation study of a population environmentally exposed to arsenic in drinking water. Environ Health Perspect. 1996 Jun;104(6):620–628. [PMC free article] [PubMed] [Google Scholar]
- Hopenhayn-Rich C, Browning SR, Hertz-Picciotto I, Ferreccio C, Peralta C, Gibb H. Chronic arsenic exposure and risk of infant mortality in two areas of Chile. Environ Health Perspect. 2000 Jul;108(7):667–673. [PMC free article] [PubMed] [Google Scholar]
- Hsueh YM, Huang YL, Huang CC, Wu WL, Chen HM, Yang MH, Lue LC, Chen CJ. Urinary levels of inorganic and organic arsenic metabolites among residents in an arseniasis-hyperendemic area in Taiwan. J Toxicol Environ Health A. 1998 Jul 24;54(6):431–444. [PubMed] [Google Scholar]
- Kalman DA, Hughes J, van Belle G, Burbacher T, Bolgiano D, Coble K, Mottet NK, Polissar L. The effect of variable environmental arsenic contamination on urinary concentrations of arsenic species. Environ Health Perspect. 1990 Nov;89:145–151. [PMC free article] [PubMed] [Google Scholar]
- Kurttio P, Komulainen H, Hakala E, Kahelin H, Pekkanen J. Urinary excretion of arsenic species after exposure to arsenic present in drinking water. Arch Environ Contam Toxicol. 1998 Apr;34(3):297–305. [PubMed] [Google Scholar]
- Le XC, Ma M, Cullen WR, Aposhian HV, Lu X, Zheng B. Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine. Environ Health Perspect. 2000 Nov;108(11):1015–1018. [PMC free article] [PubMed] [Google Scholar]
- Paik MK, Lee KH, Hson SS, Park IM, Hong JH, Hwang BD. Human placental protein methylase--I. Purification and characterization. Int J Biochem. 1991;23(9):939–945. [PubMed] [Google Scholar]
- Styblo M, Del Razo LM, Vega L, Germolec DR, LeCluyse EL, Hamilton GA, Reed W, Wang C, Cullen WR, Thomas DJ. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch Toxicol. 2000 Aug;74(6):289–299. [PubMed] [Google Scholar]
- Stýblo Miroslav, Drobná Zuzana, Jaspers Ilona, Lin Shan, Thomas David J. The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update. Environ Health Perspect. 2002 Oct;110 (Suppl 5):767–771. [PMC free article] [PubMed] [Google Scholar]
- Vahter M, Concha G. Role of metabolism in arsenic toxicity. Pharmacol Toxicol. 2001 Jul;89(1):1–5. [PubMed] [Google Scholar]
- Vahter M, Concha G, Nermell B, Nilsson R, Dulout F, Natarajan AT. A unique metabolism of inorganic arsenic in native Andean women. Eur J Pharmacol. 1995 Dec 7;293(4):455–462. [PubMed] [Google Scholar]